MedTrace Logo

Dutch Registry of Pediatric Cardiac Arrest

NCT06938009 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-04-22

No results posted yet for this study

Summary

The goal of this observational study is to understand the long-term outcomes of children in the Netherlands who experience cardiac arrest, either in or outside of the hospital. The main questions it aims to answer are:

What are the survival rates and neurological outcomes in children after cardiac arrest?

What types of emergency and post-resuscitation care are provided, and how do they impact long-term recovery?

How do children and their families function over time after the event?

Researchers will analyze data from routine medical records and follow patients through standard outpatient visits. No extra procedures will be required beyond normal care. For those who survive to hospital discharge, additional follow-up data will be collected with consent.

Participants will:

Be children under 18 years old who have had a cardiac arrest and were treated in one of the seven participating academic hospitals

Have their routine medical care data collected anonymously

Be invited (if surviving) for follow-up visits at 3, 12, and 24 months post-arrest and at specific ages (5, 8, 12, and 17 years) to assess physical and psychological recovery

Conditions

  • Cardiac Arrest (CA)
  • Pediatric ALL

Sponsors & Collaborators

  • Amsterdam UMC

    collaborator OTHER

  • Radboud University Medical Center

    collaborator OTHER

  • UMCG

    collaborator OTHER

  • Maastricht University Medical Center

    collaborator OTHER

  • UMC Utrecht

    collaborator OTHER

  • Zoll Medical Corporation

    collaborator INDUSTRY

  • Stichting Vermeer14

    collaborator UNKNOWN

  • Leiden University Medical Center

    collaborator OTHER

  • Matthijs de Hoog

    lead OTHER

Principal Investigators

  • Corinne Buysse, MD PhD · Erasmus Medical Center

Eligibility

Min Age
24 Hours
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-14
Primary Completion
2030-01-31
Completion
2030-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06938009 on ClinicalTrials.gov